Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.803
+0.042 (2.41%)
At close: Jun 27, 2025, 4:00 PM
1.820
+0.018 (0.97%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $4.80 million as of June 27, 2025. Its market cap has increased by 20.73% in one year.
Market Cap
4.80M
Enterprise Value
4.24M
1-Year Change
20.73%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $4.80M, a decrease of -88.35%. That is a compound annual growth rate of -46.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 3.80M | -3.07% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |